nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—CYP2C19—Citalopram—alcohol dependence	0.109	1	CbGbCtD
Famotidine—HRH2—gastric juice—alcohol dependence	0.0779	0.453	CbGeAlD
Famotidine—SLC22A2—Abacavir transport and metabolism—ADH1A—alcohol dependence	0.0176	0.0801	CbGpPWpGaD
Famotidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—alcohol dependence	0.0094	0.0428	CbGpPWpGaD
Famotidine—Sneezing—Naltrexone—alcohol dependence	0.00781	0.0157	CcSEcCtD
Famotidine—Supraventricular extrasystoles—Citalopram—alcohol dependence	0.00736	0.0147	CcSEcCtD
Famotidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—alcohol dependence	0.00732	0.0333	CbGpPWpGaD
Famotidine—Psychotic disorder—Disulfiram—alcohol dependence	0.00658	0.0132	CcSEcCtD
Famotidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—alcohol dependence	0.00618	0.0281	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—CHRM2—alcohol dependence	0.00618	0.0281	CbGpPWpGaD
Famotidine—Grand mal convulsion—Citalopram—alcohol dependence	0.00576	0.0115	CcSEcCtD
Famotidine—HRH2—cardiovascular system—alcohol dependence	0.00572	0.0333	CbGeAlD
Famotidine—Abdominal discomfort—Disulfiram—alcohol dependence	0.00558	0.0112	CcSEcCtD
Famotidine—SLC47A1—brainstem—alcohol dependence	0.00541	0.0315	CbGeAlD
Famotidine—Erectile dysfunction—Disulfiram—alcohol dependence	0.00536	0.0107	CcSEcCtD
Famotidine—HRH2—Amine ligand-binding receptors—CHRM2—alcohol dependence	0.00519	0.0236	CbGpPWpGaD
Famotidine—Jaundice—Disulfiram—alcohol dependence	0.00506	0.0101	CcSEcCtD
Famotidine—HRH2—Monoamine GPCRs—HTR1B—alcohol dependence	0.00504	0.0229	CbGpPWpGaD
Famotidine—SLC47A1—adrenal cortex—alcohol dependence	0.00484	0.0281	CbGeAlD
Famotidine—HRH2—digestive system—alcohol dependence	0.00475	0.0276	CbGeAlD
Famotidine—Hepatitis—Disulfiram—alcohol dependence	0.00466	0.00934	CcSEcCtD
Famotidine—Neck pain—Acamprosate—alcohol dependence	0.00463	0.00927	CcSEcCtD
Famotidine—HRH2—blood—alcohol dependence	0.00453	0.0263	CbGeAlD
Famotidine—HRH2—Monoamine GPCRs—DRD4—alcohol dependence	0.0044	0.02	CbGpPWpGaD
Famotidine—SLC22A2—digestive system—alcohol dependence	0.00433	0.0252	CbGeAlD
Famotidine—Electrocardiogram QT prolonged—Citalopram—alcohol dependence	0.00427	0.00856	CcSEcCtD
Famotidine—HRH2—Amine ligand-binding receptors—HTR1B—alcohol dependence	0.00423	0.0193	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—HTR7—alcohol dependence	0.0041	0.0187	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—DRD2—alcohol dependence	0.0041	0.0187	CbGpPWpGaD
Famotidine—Menstrual disorder—Citalopram—alcohol dependence	0.00402	0.00806	CcSEcCtD
Famotidine—SLC47A1—gonad—alcohol dependence	0.00401	0.0233	CbGeAlD
Famotidine—HRH2—endocrine gland—alcohol dependence	0.00393	0.0228	CbGeAlD
Famotidine—HRH2—Amine ligand-binding receptors—DRD4—alcohol dependence	0.0037	0.0168	CbGpPWpGaD
Famotidine—HRH2—nervous system—alcohol dependence	0.00367	0.0213	CbGeAlD
Famotidine—SLC47A1—digestive system—alcohol dependence	0.00367	0.0213	CbGeAlD
Famotidine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—alcohol dependence	0.00367	0.0167	CbGpPWpGaD
Famotidine—Libido decreased—Acamprosate—alcohol dependence	0.00358	0.00717	CcSEcCtD
Famotidine—Swelling—Naltrexone—alcohol dependence	0.00356	0.00713	CcSEcCtD
Famotidine—HRH2—liver—alcohol dependence	0.00354	0.0206	CbGeAlD
Famotidine—HRH2—central nervous system—alcohol dependence	0.00354	0.0206	CbGeAlD
Famotidine—Disorientation—Naltrexone—alcohol dependence	0.00351	0.00703	CcSEcCtD
Famotidine—SLC47A1—blood—alcohol dependence	0.00349	0.0203	CbGeAlD
Famotidine—Gingivitis—Citalopram—alcohol dependence	0.00349	0.007	CcSEcCtD
Famotidine—HRH2—Amine ligand-binding receptors—DRD2—alcohol dependence	0.00345	0.0157	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—HTR7—alcohol dependence	0.00345	0.0157	CbGpPWpGaD
Famotidine—Nasal congestion—Naltrexone—alcohol dependence	0.00345	0.00691	CcSEcCtD
Famotidine—Libido decreased—Naltrexone—alcohol dependence	0.00339	0.00679	CcSEcCtD
Famotidine—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.00329	0.0066	CcSEcCtD
Famotidine—Migraine—Acamprosate—alcohol dependence	0.00327	0.00655	CcSEcCtD
Famotidine—CYP2C19—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00326	0.0148	CbGpPWpGaD
Famotidine—Acne—Citalopram—alcohol dependence	0.00326	0.00653	CcSEcCtD
Famotidine—Psychotic disorder—Acamprosate—alcohol dependence	0.00324	0.00649	CcSEcCtD
Famotidine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—alcohol dependence	0.00323	0.0147	CbGpPWpGaD
Famotidine—Face oedema—Acamprosate—alcohol dependence	0.0032	0.00642	CcSEcCtD
Famotidine—Pain in extremity—Naltrexone—alcohol dependence	0.00314	0.00629	CcSEcCtD
Famotidine—Disturbance in sexual arousal—Naltrexone—alcohol dependence	0.00312	0.00624	CcSEcCtD
Famotidine—Rhabdomyolysis—Citalopram—alcohol dependence	0.0031	0.00621	CcSEcCtD
Famotidine—Migraine—Naltrexone—alcohol dependence	0.00309	0.00619	CcSEcCtD
Famotidine—Psychotic disorder—Naltrexone—alcohol dependence	0.00307	0.00615	CcSEcCtD
Famotidine—Dry skin—Acamprosate—alcohol dependence	0.00304	0.0061	CcSEcCtD
Famotidine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—alcohol dependence	0.00303	0.0138	CbGpPWpGaD
Famotidine—Viral infection—Citalopram—alcohol dependence	0.00303	0.00608	CcSEcCtD
Famotidine—Face oedema—Naltrexone—alcohol dependence	0.00303	0.00607	CcSEcCtD
Famotidine—SLC47A1—endocrine gland—alcohol dependence	0.00303	0.0176	CbGeAlD
Famotidine—Irritability—Naltrexone—alcohol dependence	0.003	0.00601	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00299	0.00599	CcSEcCtD
Famotidine—Paraesthesia—Disulfiram—alcohol dependence	0.00297	0.00596	CcSEcCtD
Famotidine—Somnolence—Disulfiram—alcohol dependence	0.00294	0.0059	CcSEcCtD
Famotidine—SLC47A1—testis—alcohol dependence	0.00289	0.0168	CbGeAlD
Famotidine—HRH2—Monoamine GPCRs—HTR2A—alcohol dependence	0.00287	0.0131	CbGpPWpGaD
Famotidine—Influenza—Acamprosate—alcohol dependence	0.00287	0.00575	CcSEcCtD
Famotidine—Fatigue—Disulfiram—alcohol dependence	0.00285	0.00572	CcSEcCtD
Famotidine—SLC47A1—nervous system—alcohol dependence	0.00284	0.0165	CbGeAlD
Famotidine—Pain—Disulfiram—alcohol dependence	0.00283	0.00567	CcSEcCtD
Famotidine—Cramp muscle—Naltrexone—alcohol dependence	0.00283	0.00567	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00283	0.00567	CcSEcCtD
Famotidine—HRH2—brain—alcohol dependence	0.00281	0.0163	CbGeAlD
Famotidine—Musculoskeletal pain—Citalopram—alcohol dependence	0.00277	0.00556	CcSEcCtD
Famotidine—Neck pain—Citalopram—alcohol dependence	0.00277	0.00556	CcSEcCtD
Famotidine—Bronchitis—Acamprosate—alcohol dependence	0.00276	0.00553	CcSEcCtD
Famotidine—SLC47A1—liver—alcohol dependence	0.00273	0.0159	CbGeAlD
Famotidine—SLC47A1—central nervous system—alcohol dependence	0.00273	0.0159	CbGeAlD
Famotidine—Influenza—Naltrexone—alcohol dependence	0.00271	0.00544	CcSEcCtD
Famotidine—SLC22A8—blood—alcohol dependence	0.00268	0.0156	CbGeAlD
Famotidine—SLC47A1—cerebellum—alcohol dependence	0.00267	0.0155	CbGeAlD
Famotidine—Wheezing—Citalopram—alcohol dependence	0.00266	0.00533	CcSEcCtD
Famotidine—Influenza like illness—Citalopram—alcohol dependence	0.00266	0.00533	CcSEcCtD
Famotidine—Pollakiuria—Acamprosate—alcohol dependence	0.00265	0.00531	CcSEcCtD
Famotidine—Erectile dysfunction—Acamprosate—alcohol dependence	0.00264	0.00529	CcSEcCtD
Famotidine—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00262	0.00525	CcSEcCtD
Famotidine—Bronchitis—Naltrexone—alcohol dependence	0.00261	0.00523	CcSEcCtD
Famotidine—Abdominal discomfort—Naltrexone—alcohol dependence	0.0026	0.00521	CcSEcCtD
Famotidine—Depression—Acamprosate—alcohol dependence	0.00255	0.00511	CcSEcCtD
Famotidine—SLC22A2—Amine compound SLC transporters—SLC6A3—alcohol dependence	0.00254	0.0116	CbGpPWpGaD
Famotidine—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00252	0.00505	CcSEcCtD
Famotidine—Gynaecomastia—Citalopram—alcohol dependence	0.00245	0.00491	CcSEcCtD
Famotidine—Haematuria—Acamprosate—alcohol dependence	0.00244	0.00489	CcSEcCtD
Famotidine—HRH2—Amine ligand-binding receptors—HTR2A—alcohol dependence	0.00241	0.011	CbGpPWpGaD
Famotidine—Depression—Naltrexone—alcohol dependence	0.00241	0.00483	CcSEcCtD
Famotidine—Asthenia—Disulfiram—alcohol dependence	0.00238	0.00476	CcSEcCtD
Famotidine—CYP2C19—digestive system—alcohol dependence	0.00236	0.0137	CbGeAlD
Famotidine—Ear pain—Citalopram—alcohol dependence	0.00233	0.00467	CcSEcCtD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.0023	0.0105	CbGpPWpGaD
Famotidine—Hepatitis—Acamprosate—alcohol dependence	0.0023	0.0046	CcSEcCtD
Famotidine—Hallucination—Acamprosate—alcohol dependence	0.00228	0.00458	CcSEcCtD
Famotidine—HRH2—G alpha (s) signalling events—CRHR1—alcohol dependence	0.00228	0.0104	CbGpPWpGaD
Famotidine—Pharyngitis—Acamprosate—alcohol dependence	0.00228	0.00457	CcSEcCtD
Famotidine—Sinusitis—Naltrexone—alcohol dependence	0.00227	0.00455	CcSEcCtD
Famotidine—CYP2C19—blood—alcohol dependence	0.00225	0.0131	CbGeAlD
Famotidine—Disorientation—Citalopram—alcohol dependence	0.00222	0.00446	CcSEcCtD
Famotidine—Dizziness—Disulfiram—alcohol dependence	0.00219	0.00439	CcSEcCtD
Famotidine—Nasal congestion—Citalopram—alcohol dependence	0.00218	0.00438	CcSEcCtD
Famotidine—SLC22A8—nervous system—alcohol dependence	0.00218	0.0126	CbGeAlD
Famotidine—Hepatitis—Naltrexone—alcohol dependence	0.00217	0.00435	CcSEcCtD
Famotidine—SLC47A1—brain—alcohol dependence	0.00217	0.0126	CbGeAlD
Famotidine—Hallucination—Naltrexone—alcohol dependence	0.00216	0.00433	CcSEcCtD
Famotidine—Pharyngitis—Naltrexone—alcohol dependence	0.00216	0.00432	CcSEcCtD
Famotidine—Libido decreased—Citalopram—alcohol dependence	0.00215	0.0043	CcSEcCtD
Famotidine—Tinnitus—Acamprosate—alcohol dependence	0.00214	0.00429	CcSEcCtD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.00212	0.00963	CbGpPWpGaD
Famotidine—SLC22A8—central nervous system—alcohol dependence	0.0021	0.0122	CbGeAlD
Famotidine—Rash—Disulfiram—alcohol dependence	0.00209	0.00418	CcSEcCtD
Famotidine—Headache—Disulfiram—alcohol dependence	0.00207	0.00416	CcSEcCtD
Famotidine—Alopecia—Acamprosate—alcohol dependence	0.00203	0.00407	CcSEcCtD
Famotidine—Tinnitus—Naltrexone—alcohol dependence	0.00203	0.00406	CcSEcCtD
Famotidine—CYP2C19—Xenobiotics—CYP2E1—alcohol dependence	0.00202	0.0092	CbGpPWpGaD
Famotidine—Mental disorder—Acamprosate—alcohol dependence	0.00201	0.00403	CcSEcCtD
Famotidine—Pain in extremity—Citalopram—alcohol dependence	0.00199	0.00399	CcSEcCtD
Famotidine—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.00197	0.00396	CcSEcCtD
Famotidine—Migraine—Citalopram—alcohol dependence	0.00196	0.00392	CcSEcCtD
Famotidine—Dysgeusia—Acamprosate—alcohol dependence	0.00196	0.00392	CcSEcCtD
Famotidine—CYP2C19—endocrine gland—alcohol dependence	0.00195	0.0113	CbGeAlD
Famotidine—CYP2C19—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00194	0.00885	CbGpPWpGaD
Famotidine—Psychotic disorder—Citalopram—alcohol dependence	0.00194	0.00389	CcSEcCtD
Famotidine—Back pain—Acamprosate—alcohol dependence	0.00193	0.00387	CcSEcCtD
Famotidine—Muscle spasms—Acamprosate—alcohol dependence	0.00192	0.00385	CcSEcCtD
Famotidine—Face oedema—Citalopram—alcohol dependence	0.00192	0.00385	CcSEcCtD
Famotidine—Alopecia—Naltrexone—alcohol dependence	0.00192	0.00385	CcSEcCtD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00191	0.00867	CbGpPWpGaD
Famotidine—Mental disorder—Naltrexone—alcohol dependence	0.0019	0.00381	CcSEcCtD
Famotidine—Irritability—Citalopram—alcohol dependence	0.0019	0.00381	CcSEcCtD
Famotidine—Dysgeusia—Naltrexone—alcohol dependence	0.00185	0.00371	CcSEcCtD
Famotidine—Anaemia—Acamprosate—alcohol dependence	0.00185	0.0037	CcSEcCtD
Famotidine—Agitation—Acamprosate—alcohol dependence	0.00184	0.00368	CcSEcCtD
Famotidine—Back pain—Naltrexone—alcohol dependence	0.00183	0.00367	CcSEcCtD
Famotidine—Angioedema—Acamprosate—alcohol dependence	0.00183	0.00366	CcSEcCtD
Famotidine—Dry skin—Citalopram—alcohol dependence	0.00182	0.00365	CcSEcCtD
Famotidine—Muscle spasms—Naltrexone—alcohol dependence	0.00182	0.00364	CcSEcCtD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.00181	0.00825	CbGpPWpGaD
Famotidine—Syncope—Acamprosate—alcohol dependence	0.00179	0.00359	CcSEcCtD
Famotidine—Cramp muscle—Citalopram—alcohol dependence	0.00179	0.00359	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.00179	0.00359	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00179	0.00359	CcSEcCtD
Famotidine—Leukopenia—Acamprosate—alcohol dependence	0.00179	0.00358	CcSEcCtD
Famotidine—Palpitations—Acamprosate—alcohol dependence	0.00177	0.00354	CcSEcCtD
Famotidine—CYP2C19—liver—alcohol dependence	0.00176	0.0102	CbGeAlD
Famotidine—Loss of consciousness—Acamprosate—alcohol dependence	0.00176	0.00352	CcSEcCtD
Famotidine—HRH2—G alpha (s) signalling events—CRH—alcohol dependence	0.00175	0.00795	CbGpPWpGaD
Famotidine—Cough—Acamprosate—alcohol dependence	0.00174	0.00349	CcSEcCtD
Famotidine—Agitation—Naltrexone—alcohol dependence	0.00174	0.00348	CcSEcCtD
Famotidine—Convulsion—Acamprosate—alcohol dependence	0.00173	0.00347	CcSEcCtD
Famotidine—Angioedema—Naltrexone—alcohol dependence	0.00173	0.00346	CcSEcCtD
Famotidine—Influenza—Citalopram—alcohol dependence	0.00172	0.00345	CcSEcCtD
Famotidine—Myalgia—Acamprosate—alcohol dependence	0.0017	0.00341	CcSEcCtD
Famotidine—Chest pain—Acamprosate—alcohol dependence	0.0017	0.00341	CcSEcCtD
Famotidine—Arthralgia—Acamprosate—alcohol dependence	0.0017	0.00341	CcSEcCtD
Famotidine—Syncope—Naltrexone—alcohol dependence	0.0017	0.0034	CcSEcCtD
Famotidine—Anxiety—Acamprosate—alcohol dependence	0.0017	0.0034	CcSEcCtD
Famotidine—Bronchospasm—Citalopram—alcohol dependence	0.00169	0.00339	CcSEcCtD
Famotidine—Palpitations—Naltrexone—alcohol dependence	0.00167	0.00335	CcSEcCtD
Famotidine—Dry mouth—Acamprosate—alcohol dependence	0.00166	0.00333	CcSEcCtD
Famotidine—SLC22A8—brain—alcohol dependence	0.00166	0.00966	CbGeAlD
Famotidine—Loss of consciousness—Naltrexone—alcohol dependence	0.00166	0.00333	CcSEcCtD
Famotidine—Bronchitis—Citalopram—alcohol dependence	0.00165	0.00331	CcSEcCtD
Famotidine—Cough—Naltrexone—alcohol dependence	0.00165	0.00331	CcSEcCtD
Famotidine—Abdominal discomfort—Citalopram—alcohol dependence	0.00165	0.0033	CcSEcCtD
Famotidine—Confusional state—Acamprosate—alcohol dependence	0.00164	0.0033	CcSEcCtD
Famotidine—SLC22A2—Neurotransmitter Release Cycle—MAOA—alcohol dependence	0.00164	0.00747	CbGpPWpGaD
Famotidine—Convulsion—Naltrexone—alcohol dependence	0.00164	0.00328	CcSEcCtD
Famotidine—Pancytopenia—Citalopram—alcohol dependence	0.00163	0.00327	CcSEcCtD
Famotidine—Anaphylactic shock—Acamprosate—alcohol dependence	0.00163	0.00327	CcSEcCtD
Famotidine—Infection—Acamprosate—alcohol dependence	0.00162	0.00325	CcSEcCtD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00162	0.00737	CbGpPWpGaD
Famotidine—Arthralgia—Naltrexone—alcohol dependence	0.00161	0.00323	CcSEcCtD
Famotidine—Myalgia—Naltrexone—alcohol dependence	0.00161	0.00323	CcSEcCtD
Famotidine—Chest pain—Naltrexone—alcohol dependence	0.00161	0.00323	CcSEcCtD
Famotidine—Dysuria—Citalopram—alcohol dependence	0.00161	0.00322	CcSEcCtD
Famotidine—Shock—Acamprosate—alcohol dependence	0.0016	0.00322	CcSEcCtD
Famotidine—Anxiety—Naltrexone—alcohol dependence	0.0016	0.00321	CcSEcCtD
Famotidine—SLC22A2—Transmission across Chemical Synapses—KCNJ6—alcohol dependence	0.0016	0.00729	CbGpPWpGaD
Famotidine—Upper respiratory tract infection—Citalopram—alcohol dependence	0.0016	0.0032	CcSEcCtD
Famotidine—Thrombocytopenia—Acamprosate—alcohol dependence	0.0016	0.0032	CcSEcCtD
Famotidine—Pollakiuria—Citalopram—alcohol dependence	0.00159	0.00318	CcSEcCtD
Famotidine—Erectile dysfunction—Citalopram—alcohol dependence	0.00158	0.00317	CcSEcCtD
Famotidine—Dry mouth—Naltrexone—alcohol dependence	0.00157	0.00315	CcSEcCtD
Famotidine—Photosensitivity reaction—Citalopram—alcohol dependence	0.00157	0.00315	CcSEcCtD
Famotidine—Confusional state—Naltrexone—alcohol dependence	0.00156	0.00312	CcSEcCtD
Famotidine—Anorexia—Acamprosate—alcohol dependence	0.00155	0.00312	CcSEcCtD
Famotidine—Oedema—Naltrexone—alcohol dependence	0.00154	0.00309	CcSEcCtD
Famotidine—Anaphylactic shock—Naltrexone—alcohol dependence	0.00154	0.00309	CcSEcCtD
Famotidine—Infection—Naltrexone—alcohol dependence	0.00153	0.00307	CcSEcCtD
Famotidine—Depression—Citalopram—alcohol dependence	0.00153	0.00306	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.00152	0.00305	CcSEcCtD
Famotidine—Shock—Naltrexone—alcohol dependence	0.00152	0.00304	CcSEcCtD
Famotidine—Jaundice—Citalopram—alcohol dependence	0.00149	0.00299	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00149	0.00298	CcSEcCtD
Famotidine—Insomnia—Acamprosate—alcohol dependence	0.00148	0.00296	CcSEcCtD
Famotidine—Anorexia—Naltrexone—alcohol dependence	0.00147	0.00295	CcSEcCtD
Famotidine—Paraesthesia—Acamprosate—alcohol dependence	0.00146	0.00294	CcSEcCtD
Famotidine—Haematuria—Citalopram—alcohol dependence	0.00146	0.00293	CcSEcCtD
Famotidine—SLC47A1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.00146	0.00663	CbGpPWpGaD
Famotidine—Somnolence—Acamprosate—alcohol dependence	0.00145	0.00291	CcSEcCtD
Famotidine—Sinusitis—Citalopram—alcohol dependence	0.00144	0.00288	CcSEcCtD
Famotidine—Dyspepsia—Acamprosate—alcohol dependence	0.00144	0.00288	CcSEcCtD
Famotidine—Agranulocytosis—Citalopram—alcohol dependence	0.00143	0.00287	CcSEcCtD
Famotidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—alcohol dependence	0.00143	0.00651	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.00142	0.00648	CbGpPWpGaD
Famotidine—HRH2—G alpha (s) signalling events—HTR7—alcohol dependence	0.00142	0.00647	CbGpPWpGaD
Famotidine—Decreased appetite—Acamprosate—alcohol dependence	0.00142	0.00284	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00141	0.00282	CcSEcCtD
Famotidine—Bradycardia—Citalopram—alcohol dependence	0.0014	0.00281	CcSEcCtD
Famotidine—Insomnia—Naltrexone—alcohol dependence	0.0014	0.0028	CcSEcCtD
Famotidine—Constipation—Acamprosate—alcohol dependence	0.00139	0.0028	CcSEcCtD
Famotidine—Pain—Acamprosate—alcohol dependence	0.00139	0.0028	CcSEcCtD
Famotidine—Paraesthesia—Naltrexone—alcohol dependence	0.00139	0.00278	CcSEcCtD
Famotidine—HRH2—GPCR ligand binding—OPRK1—alcohol dependence	0.00138	0.00629	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.00138	0.00628	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00138	0.00627	CbGpPWpGaD
Famotidine—Hepatitis—Citalopram—alcohol dependence	0.00138	0.00276	CcSEcCtD
Famotidine—Somnolence—Naltrexone—alcohol dependence	0.00137	0.00275	CcSEcCtD
Famotidine—Hallucination—Citalopram—alcohol dependence	0.00137	0.00274	CcSEcCtD
Famotidine—Pharyngitis—Citalopram—alcohol dependence	0.00137	0.00274	CcSEcCtD
Famotidine—Feeling abnormal—Acamprosate—alcohol dependence	0.00134	0.00269	CcSEcCtD
Famotidine—Decreased appetite—Naltrexone—alcohol dependence	0.00134	0.00269	CcSEcCtD
Famotidine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00133	0.00267	CcSEcCtD
Famotidine—Fatigue—Naltrexone—alcohol dependence	0.00133	0.00267	CcSEcCtD
Famotidine—Pain—Naltrexone—alcohol dependence	0.00132	0.00264	CcSEcCtD
Famotidine—Constipation—Naltrexone—alcohol dependence	0.00132	0.00264	CcSEcCtD
Famotidine—Erythema multiforme—Citalopram—alcohol dependence	0.0013	0.00261	CcSEcCtD
Famotidine—Urticaria—Acamprosate—alcohol dependence	0.0013	0.0026	CcSEcCtD
Famotidine—Body temperature increased—Acamprosate—alcohol dependence	0.00129	0.00258	CcSEcCtD
Famotidine—Abdominal pain—Acamprosate—alcohol dependence	0.00129	0.00258	CcSEcCtD
Famotidine—Tinnitus—Citalopram—alcohol dependence	0.00128	0.00257	CcSEcCtD
Famotidine—Flushing—Citalopram—alcohol dependence	0.00128	0.00256	CcSEcCtD
Famotidine—Feeling abnormal—Naltrexone—alcohol dependence	0.00127	0.00255	CcSEcCtD
Famotidine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00126	0.00253	CcSEcCtD
Famotidine—SLC47A1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.00124	0.00563	CbGpPWpGaD
Famotidine—CYP2C19—Melatonin metabolism and effects—MAOA—alcohol dependence	0.00124	0.00562	CbGpPWpGaD
Famotidine—Arrhythmia—Citalopram—alcohol dependence	0.00123	0.00246	CcSEcCtD
Famotidine—SLC22A2—Neuronal System—KCNJ6—alcohol dependence	0.00123	0.00559	CbGpPWpGaD
Famotidine—Urticaria—Naltrexone—alcohol dependence	0.00123	0.00246	CcSEcCtD
Famotidine—CYP2C19—Biological oxidations—ADH6—alcohol dependence	0.00122	0.00556	CbGpPWpGaD
Famotidine—Abdominal pain—Naltrexone—alcohol dependence	0.00122	0.00244	CcSEcCtD
Famotidine—Body temperature increased—Naltrexone—alcohol dependence	0.00122	0.00244	CcSEcCtD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.00122	0.00555	CbGpPWpGaD
Famotidine—Alopecia—Citalopram—alcohol dependence	0.00122	0.00244	CcSEcCtD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00121	0.0055	CbGpPWpGaD
Famotidine—Mental disorder—Citalopram—alcohol dependence	0.00121	0.00242	CcSEcCtD
Famotidine—Hypersensitivity—Acamprosate—alcohol dependence	0.0012	0.00241	CcSEcCtD
Famotidine—HRH2—G alpha (s) signalling events—AVP—alcohol dependence	0.0012	0.00545	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.00119	0.00543	CbGpPWpGaD
Famotidine—Dysgeusia—Citalopram—alcohol dependence	0.00117	0.00235	CcSEcCtD
Famotidine—Asthenia—Acamprosate—alcohol dependence	0.00117	0.00235	CcSEcCtD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.00117	0.00532	CbGpPWpGaD
Famotidine—Back pain—Citalopram—alcohol dependence	0.00116	0.00232	CcSEcCtD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GABRB1—alcohol dependence	0.00116	0.00527	CbGpPWpGaD
Famotidine—Pruritus—Acamprosate—alcohol dependence	0.00115	0.00231	CcSEcCtD
Famotidine—Muscle spasms—Citalopram—alcohol dependence	0.00115	0.00231	CcSEcCtD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.00114	0.00519	CbGpPWpGaD
Famotidine—Hypersensitivity—Naltrexone—alcohol dependence	0.00114	0.00228	CcSEcCtD
Famotidine—Diarrhoea—Acamprosate—alcohol dependence	0.00112	0.00224	CcSEcCtD
Famotidine—Anaemia—Citalopram—alcohol dependence	0.00111	0.00222	CcSEcCtD
Famotidine—Asthenia—Naltrexone—alcohol dependence	0.00111	0.00222	CcSEcCtD
Famotidine—Agitation—Citalopram—alcohol dependence	0.0011	0.00221	CcSEcCtD
Famotidine—Angioedema—Citalopram—alcohol dependence	0.00109	0.00219	CcSEcCtD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.00109	0.00498	CbGpPWpGaD
Famotidine—Pruritus—Naltrexone—alcohol dependence	0.00109	0.00219	CcSEcCtD
Famotidine—Dizziness—Acamprosate—alcohol dependence	0.00108	0.00216	CcSEcCtD
Famotidine—Syncope—Citalopram—alcohol dependence	0.00107	0.00215	CcSEcCtD
Famotidine—Leukopenia—Citalopram—alcohol dependence	0.00107	0.00215	CcSEcCtD
Famotidine—Palpitations—Citalopram—alcohol dependence	0.00106	0.00212	CcSEcCtD
Famotidine—Diarrhoea—Naltrexone—alcohol dependence	0.00106	0.00212	CcSEcCtD
Famotidine—Loss of consciousness—Citalopram—alcohol dependence	0.00105	0.00211	CcSEcCtD
Famotidine—Cough—Citalopram—alcohol dependence	0.00105	0.0021	CcSEcCtD
Famotidine—Convulsion—Citalopram—alcohol dependence	0.00104	0.00208	CcSEcCtD
Famotidine—Vomiting—Acamprosate—alcohol dependence	0.00104	0.00208	CcSEcCtD
Famotidine—Rash—Acamprosate—alcohol dependence	0.00103	0.00206	CcSEcCtD
Famotidine—Dermatitis—Acamprosate—alcohol dependence	0.00103	0.00206	CcSEcCtD
Famotidine—Headache—Acamprosate—alcohol dependence	0.00102	0.00205	CcSEcCtD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.00102	0.00465	CbGpPWpGaD
Famotidine—Dizziness—Naltrexone—alcohol dependence	0.00102	0.00205	CcSEcCtD
Famotidine—Chest pain—Citalopram—alcohol dependence	0.00102	0.00204	CcSEcCtD
Famotidine—Arthralgia—Citalopram—alcohol dependence	0.00102	0.00204	CcSEcCtD
Famotidine—Myalgia—Citalopram—alcohol dependence	0.00102	0.00204	CcSEcCtD
Famotidine—Anxiety—Citalopram—alcohol dependence	0.00102	0.00204	CcSEcCtD
Famotidine—CYP2C19—Biological oxidations—ADH1A—alcohol dependence	0.00101	0.00461	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.001	0.00455	CbGpPWpGaD
Famotidine—Dry mouth—Citalopram—alcohol dependence	0.000998	0.002	CcSEcCtD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—alcohol dependence	0.000995	0.00453	CbGpPWpGaD
Famotidine—Confusional state—Citalopram—alcohol dependence	0.000986	0.00198	CcSEcCtD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GABRA2—alcohol dependence	0.000985	0.00448	CbGpPWpGaD
Famotidine—Vomiting—Naltrexone—alcohol dependence	0.000981	0.00197	CcSEcCtD
Famotidine—Oedema—Citalopram—alcohol dependence	0.000978	0.00196	CcSEcCtD
Famotidine—Anaphylactic shock—Citalopram—alcohol dependence	0.000978	0.00196	CcSEcCtD
Famotidine—Rash—Naltrexone—alcohol dependence	0.000973	0.00195	CcSEcCtD
Famotidine—Dermatitis—Naltrexone—alcohol dependence	0.000972	0.00195	CcSEcCtD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.000972	0.00442	CbGpPWpGaD
Famotidine—Infection—Citalopram—alcohol dependence	0.000971	0.00195	CcSEcCtD
Famotidine—Nausea—Acamprosate—alcohol dependence	0.000969	0.00194	CcSEcCtD
Famotidine—Headache—Naltrexone—alcohol dependence	0.000967	0.00194	CcSEcCtD
Famotidine—Shock—Citalopram—alcohol dependence	0.000962	0.00193	CcSEcCtD
Famotidine—Thrombocytopenia—Citalopram—alcohol dependence	0.000957	0.00192	CcSEcCtD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.000938	0.00427	CbGpPWpGaD
Famotidine—Anorexia—Citalopram—alcohol dependence	0.000932	0.00187	CcSEcCtD
Famotidine—HRH2—GPCR ligand binding—OPRD1—alcohol dependence	0.000928	0.00422	CbGpPWpGaD
Famotidine—Nausea—Naltrexone—alcohol dependence	0.000917	0.00184	CcSEcCtD
Famotidine—CYP2C19—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000891	0.00406	CbGpPWpGaD
Famotidine—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000891	0.00179	CcSEcCtD
Famotidine—HRH2—GPCR ligand binding—PDYN—alcohol dependence	0.00089	0.00405	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GABRB1—alcohol dependence	0.000888	0.00404	CbGpPWpGaD
Famotidine—Insomnia—Citalopram—alcohol dependence	0.000884	0.00177	CcSEcCtD
Famotidine—Paraesthesia—Citalopram—alcohol dependence	0.000878	0.00176	CcSEcCtD
Famotidine—Somnolence—Citalopram—alcohol dependence	0.000869	0.00174	CcSEcCtD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.000863	0.00393	CbGpPWpGaD
Famotidine—Dyspepsia—Citalopram—alcohol dependence	0.000861	0.00172	CcSEcCtD
Famotidine—CYP2C19—Biological oxidations—ADH4—alcohol dependence	0.00086	0.00392	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000851	0.00387	CbGpPWpGaD
Famotidine—Decreased appetite—Citalopram—alcohol dependence	0.00085	0.0017	CcSEcCtD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.00085	0.00387	CbGpPWpGaD
Famotidine—Fatigue—Citalopram—alcohol dependence	0.000843	0.00169	CcSEcCtD
Famotidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000839	0.00382	CbGpPWpGaD
Famotidine—Constipation—Citalopram—alcohol dependence	0.000836	0.00168	CcSEcCtD
Famotidine—Pain—Citalopram—alcohol dependence	0.000836	0.00168	CcSEcCtD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.000833	0.00379	CbGpPWpGaD
Famotidine—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000828	0.00377	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CRHR1—alcohol dependence	0.000827	0.00377	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.000811	0.00369	CbGpPWpGaD
Famotidine—Feeling abnormal—Citalopram—alcohol dependence	0.000806	0.00161	CcSEcCtD
Famotidine—Gastrointestinal pain—Citalopram—alcohol dependence	0.0008	0.0016	CcSEcCtD
Famotidine—HRH2—G alpha (s) signalling events—POMC—alcohol dependence	0.000796	0.00362	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.000791	0.0036	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.000791	0.0036	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—OPRK1—alcohol dependence	0.00078	0.00355	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CHRM2—alcohol dependence	0.000778	0.00354	CbGpPWpGaD
Famotidine—Urticaria—Citalopram—alcohol dependence	0.000777	0.00156	CcSEcCtD
Famotidine—Abdominal pain—Citalopram—alcohol dependence	0.000773	0.00155	CcSEcCtD
Famotidine—Body temperature increased—Citalopram—alcohol dependence	0.000773	0.00155	CcSEcCtD
Famotidine—SLC22A2—Neuronal System—GABRA2—alcohol dependence	0.000755	0.00344	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—ADH7—alcohol dependence	0.000732	0.00333	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000728	0.00331	CbGpPWpGaD
Famotidine—Hypersensitivity—Citalopram—alcohol dependence	0.00072	0.00144	CcSEcCtD
Famotidine—SLC22A2—Transmission across Chemical Synapses—ALDH2—alcohol dependence	0.000716	0.00326	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—OPRM1—alcohol dependence	0.000714	0.00325	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—OPRK1—alcohol dependence	0.000709	0.00323	CbGpPWpGaD
Famotidine—Asthenia—Citalopram—alcohol dependence	0.000702	0.00141	CcSEcCtD
Famotidine—CYP2C19—Biological oxidations—GGT2—alcohol dependence	0.000701	0.00319	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000701	0.00319	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000695	0.00316	CbGpPWpGaD
Famotidine—Pruritus—Citalopram—alcohol dependence	0.000692	0.00139	CcSEcCtD
Famotidine—SLC22A8—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000686	0.00312	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00068	0.0031	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000678	0.00309	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000678	0.00309	CbGpPWpGaD
Famotidine—Diarrhoea—Citalopram—alcohol dependence	0.000669	0.00134	CcSEcCtD
Famotidine—HRH2—GPCR ligand binding—NPY—alcohol dependence	0.000657	0.00299	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.00065	0.00296	CbGpPWpGaD
Famotidine—Dizziness—Citalopram—alcohol dependence	0.000647	0.0013	CcSEcCtD
Famotidine—CYP2C19—Biological oxidations—ADH1B—alcohol dependence	0.000642	0.00292	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR1B—alcohol dependence	0.000634	0.00289	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CRH—alcohol dependence	0.000634	0.00289	CbGpPWpGaD
Famotidine—Vomiting—Citalopram—alcohol dependence	0.000622	0.00125	CcSEcCtD
Famotidine—Rash—Citalopram—alcohol dependence	0.000617	0.00124	CcSEcCtD
Famotidine—Dermatitis—Citalopram—alcohol dependence	0.000616	0.00123	CcSEcCtD
Famotidine—Headache—Citalopram—alcohol dependence	0.000613	0.00123	CcSEcCtD
Famotidine—SLC22A8—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000583	0.00265	CbGpPWpGaD
Famotidine—Nausea—Citalopram—alcohol dependence	0.000581	0.00116	CcSEcCtD
Famotidine—SLC47A1—Transmembrane transport of small molecules—AVP—alcohol dependence	0.00058	0.00264	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000571	0.0026	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GRIN2B—alcohol dependence	0.000566	0.00258	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00056	0.00255	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—alcohol dependence	0.000558	0.00254	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000554	0.00252	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD4—alcohol dependence	0.000554	0.00252	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—ALDH2—alcohol dependence	0.000548	0.0025	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000537	0.00245	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—MAOB—alcohol dependence	0.000532	0.00242	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CNR1—alcohol dependence	0.000529	0.00241	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—OPRD1—alcohol dependence	0.000525	0.00239	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD2—alcohol dependence	0.000516	0.00235	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR7—alcohol dependence	0.000516	0.00235	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PDYN—alcohol dependence	0.000503	0.00229	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000477	0.00217	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—OPRD1—alcohol dependence	0.000476	0.00217	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000475	0.00216	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—MAOA—alcohol dependence	0.000471	0.00214	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CRHR1—alcohol dependence	0.000468	0.00213	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PDYN—alcohol dependence	0.000457	0.00208	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000452	0.00206	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—ALDH2—alcohol dependence	0.000452	0.00206	CbGpPWpGaD
Famotidine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.00045	0.00205	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CHRM2—alcohol dependence	0.00044	0.002	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—AVP—alcohol dependence	0.000435	0.00198	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GRIN2B—alcohol dependence	0.000434	0.00197	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—SLC6A3—alcohol dependence	0.000427	0.00194	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CRHR1—alcohol dependence	0.000425	0.00193	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—OPRK1—alcohol dependence	0.000419	0.00191	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000406	0.00185	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—OPRM1—alcohol dependence	0.000404	0.00184	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CHRM2—alcohol dependence	0.000399	0.00182	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000379	0.00173	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000374	0.0017	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ADH6—alcohol dependence	0.000373	0.0017	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—NPY—alcohol dependence	0.000371	0.00169	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—OPRM1—alcohol dependence	0.000367	0.00167	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000364	0.00166	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR2A—alcohol dependence	0.000362	0.00165	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP2E1—alcohol dependence	0.000361	0.00164	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—MAOA—alcohol dependence	0.000361	0.00164	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CRH—alcohol dependence	0.000358	0.00163	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR1B—alcohol dependence	0.000358	0.00163	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000356	0.00162	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—NPY—alcohol dependence	0.000337	0.00154	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GGT1—alcohol dependence	0.000332	0.00151	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.00033	0.0015	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR1B—alcohol dependence	0.000325	0.00148	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CRH—alcohol dependence	0.000325	0.00148	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD4—alcohol dependence	0.000313	0.00143	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ADH1A—alcohol dependence	0.000309	0.00141	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CNR1—alcohol dependence	0.000299	0.00136	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—MAOA—alcohol dependence	0.000297	0.00135	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD2—alcohol dependence	0.000292	0.00133	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR7—alcohol dependence	0.000292	0.00133	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—POMC—alcohol dependence	0.000289	0.00131	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD4—alcohol dependence	0.000284	0.00129	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—OPRD1—alcohol dependence	0.000281	0.00128	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000273	0.00124	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CNR1—alcohol dependence	0.000272	0.00124	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PDYN—alcohol dependence	0.00027	0.00123	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR7—alcohol dependence	0.000265	0.00121	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD2—alcohol dependence	0.000265	0.00121	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ADH4—alcohol dependence	0.000263	0.0012	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—WASF2—alcohol dependence	0.000251	0.00114	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CRHR1—alcohol dependence	0.000251	0.00114	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AVP—alcohol dependence	0.000246	0.00112	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—WASF1—alcohol dependence	0.00024	0.00109	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CHRM2—alcohol dependence	0.000236	0.00107	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.00023	0.00105	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ADH7—alcohol dependence	0.000224	0.00102	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AVP—alcohol dependence	0.000223	0.00102	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—OPRM1—alcohol dependence	0.000217	0.000985	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GGT2—alcohol dependence	0.000214	0.000975	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADH6—alcohol dependence	0.000209	0.000951	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR2A—alcohol dependence	0.000204	0.00093	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NPY—alcohol dependence	0.000199	0.000907	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ADH1B—alcohol dependence	0.000196	0.000892	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—POMC—alcohol dependence	0.000194	0.000881	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR1B—alcohol dependence	0.000192	0.000875	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CRH—alcohol dependence	0.000192	0.000875	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—AVP—alcohol dependence	0.00019	0.000865	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR2A—alcohol dependence	0.000186	0.000845	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADH1A—alcohol dependence	0.000173	0.000788	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD4—alcohol dependence	0.000168	0.000765	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—POMC—alcohol dependence	0.000163	0.000743	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MAOB—alcohol dependence	0.000162	0.000739	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CNR1—alcohol dependence	0.00016	0.00073	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR7—alcohol dependence	0.000157	0.000712	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD2—alcohol dependence	0.000157	0.000712	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—POMC—alcohol dependence	0.000148	0.000675	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADH4—alcohol dependence	0.000147	0.00067	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALDH2—alcohol dependence	0.000138	0.000629	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AVP—alcohol dependence	0.000132	0.0006	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000127	0.00058	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADH7—alcohol dependence	0.000125	0.000569	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GGT2—alcohol dependence	0.00012	0.000546	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GOT2—alcohol dependence	0.000117	0.000534	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2E1—alcohol dependence	0.00011	0.000502	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADH1B—alcohol dependence	0.00011	0.000499	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR2A—alcohol dependence	0.00011	0.000499	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GOT1—alcohol dependence	0.000101	0.000461	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GGT1—alcohol dependence	0.000101	0.000461	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MAOB—alcohol dependence	9.09e-05	0.000414	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MAOA—alcohol dependence	9.08e-05	0.000413	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—POMC—alcohol dependence	8.76e-05	0.000398	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALDH2—alcohol dependence	7.73e-05	0.000352	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	7.43e-05	0.000338	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GOT2—alcohol dependence	6.57e-05	0.000299	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2E1—alcohol dependence	6.18e-05	0.000281	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—POMC—alcohol dependence	5.91e-05	0.000269	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EP300—alcohol dependence	5.81e-05	0.000264	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GOT1—alcohol dependence	5.67e-05	0.000258	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GGT1—alcohol dependence	5.67e-05	0.000258	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MAOA—alcohol dependence	5.08e-05	0.000231	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	4.93e-05	0.000224	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—EP300—alcohol dependence	3.92e-05	0.000179	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—POMC—alcohol dependence	3.31e-05	0.000151	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—EP300—alcohol dependence	2.2e-05	9.99e-05	CbGpPWpGaD
